A carregar...
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by large pathophysiology heterogeneity with lack of effective therapies as proven by the disappointing results generated by randomized controlled trials. The innovative therapeutic concept provided by s...
Na minha lista:
| Publicado no: | Eur Heart J Suppl |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944492/ https://ncbi.nlm.nih.gov/pubmed/33727901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa140 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|